OptiNose Future Growth
Future criteria checks 5/6
OptiNose is forecast to grow earnings and revenue by 58.9% and 25.7% per annum respectively while EPS is expected to grow by 60.9% per annum.
Key information
58.9%
Earnings growth rate
60.9%
EPS growth rate
Pharmaceuticals earnings growth | 20.7% |
Revenue growth rate | 25.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 159 | 22 | 23 | 39 | 3 |
12/31/2025 | 130 | -13 | 15 | -5 | 4 |
12/31/2024 | 90 | -31 | -1 | -35 | 4 |
12/31/2023 | 71 | -35 | -21 | -21 | N/A |
9/30/2023 | 72 | -41 | -45 | -45 | N/A |
6/30/2023 | 72 | -46 | -58 | -58 | N/A |
3/31/2023 | 73 | -68 | -59 | -59 | N/A |
12/31/2022 | 76 | -75 | -68 | -68 | N/A |
9/30/2022 | 78 | -75 | -67 | -67 | N/A |
6/30/2022 | 80 | -77 | -59 | -59 | N/A |
3/31/2022 | 77 | -82 | -68 | -68 | N/A |
12/31/2021 | 75 | -82 | -77 | -77 | N/A |
9/30/2021 | 68 | -91 | -80 | -79 | N/A |
6/30/2021 | 62 | -95 | -86 | -85 | N/A |
3/31/2021 | 54 | -97 | -87 | -86 | N/A |
12/31/2020 | 49 | -100 | -87 | -86 | N/A |
9/30/2020 | 44 | -101 | -86 | -85 | N/A |
6/30/2020 | 41 | -109 | -85 | -85 | N/A |
3/31/2020 | 37 | -110 | -90 | -89 | N/A |
12/31/2019 | 35 | -110 | -91 | -91 | N/A |
9/30/2019 | 27 | -111 | -94 | -93 | N/A |
6/30/2019 | 16 | -108 | -103 | -102 | N/A |
3/31/2019 | 11 | -105 | -100 | -99 | N/A |
12/31/2018 | 7 | -107 | -94 | -92 | N/A |
9/30/2018 | 4 | -101 | -88 | -85 | N/A |
6/30/2018 | 2 | -93 | -72 | -70 | N/A |
3/31/2018 | 1 | -81 | -54 | -51 | N/A |
12/31/2017 | N/A | -62 | -38 | -36 | N/A |
9/30/2017 | N/A | -43 | N/A | -28 | N/A |
6/30/2017 | N/A | -35 | N/A | -24 | N/A |
3/31/2017 | N/A | -46 | N/A | -24 | N/A |
12/31/2016 | 48 | 2 | N/A | 22 | N/A |
12/31/2015 | 0 | -40 | N/A | -29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0OP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.6%).
Earnings vs Market: 0OP is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0OP is expected to become profitable in the next 3 years.
Revenue vs Market: 0OP's revenue (25.7% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 0OP's revenue (25.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0OP's Return on Equity is forecast to be high in 3 years time